Top Buy
Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 1 | €11.83 | €27.83 | 135.258% |
Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.53 | €6.00 | 70.213% |
Fagron N.V. | 1 | 0 | 0 | 0 | €18.74 | €20.00 | 6.724% |
Fate Therapeutics Inc. | 5 | 2 | 2 | 0 | €3.61 | €8.27 | 129.298% |
G1 Therapeutics | 15 | 1 | 3 | 0 | €4.77 | €10.56 | 121.177% |
Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.36 | €63.93 | 17560.497% |
Geron Corp. | 12 | 0 | 4 | 0 | €3.61 | €4.63 | 28.316% |
Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
Heron Therapeutics Inc. | 10 | 1 | 4 | 0 | €2.73 | €4.58 | 67.410% |
Immunic Inc. | 6 | 3 | 0 | 2 | €1.19 | €5.48 | 361.431% |
ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.46 | €10.00 | 34.120% |
Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
Insmed Inc. | 13 | 1 | 2 | 0 | €24.00 | €44.01 | 83.361% |
Intellia Therapeutics Inc | 12 | 0 | 0 | 0 | €22.76 | €60.13 | 164.170% |
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €62.00 | €79.55 | 28.313% |
iRhythm Technologies Inc | 11 | 0 | 1 | 0 | €98.00 | €123.46 | 25.975% |
Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.23 | €19.86 | 218.859% |
Krystal Biotech | 17 | 0 | 4 | 0 | €145.65 | €179.60 | 23.306% |
Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €81.60 | €100.00 | 22.549% |
Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €69.86 | €80.00 | 14.515% |
Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €70.00 | €69.00 | -1.429% |
Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.74 | €5.34 | 206.667% |
M1 Kliniken AG | 2 | 0 | 0 | 0 | €16.50 | - | - |
MacroGenics Inc. | 11 | 0 | 2 | 0 | €13.63 | €20.00 | 46.735% |